---
layout: post
title: "昂利康：苯磺酸左氨氯地平片未中选浙江省带量采购"
date: 2022-03-02 18:44:07 +0800
categories: zhengquanshibao
tags: 证券时报新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.002940" data-code="002940|0|2" data-code2="002940|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002940&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002940_0" data-code="K 002940|0|2" data-code2="K 002940|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>昂利康(002940)3月2日晚间公告，公司近日参加了浙江省带量采购报价，根据3月2日公布的《浙江省市级联合(金华)药品带量采购拟中选药品目录》，公司产品苯磺酸左氨氯地平片未中选本次浙江省带量采购。<br /></p><p class="em_media">（文章来源：证券时报）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203022294612288>

[返回证券时报新闻](//finews.withounder.com/category/zhengquanshibao.html)｜[返回首页](//finews.withounder.com/)